Effective chronic care management for human and animal health.
We develop solutions for sustainably providing measurable health information, enabling frequent patient/provider interactions. Our technology enhances adherence-to-care-plans, improving outcomes and containing healthcare costs.
Connecting clinicians and patients.
Our diabetes management solutions shift the current patient self-care model to a more effective and efficient active patient management model by connecting the clinicians, patients, testing supplies, and health data together through our groundbreaking technology
Multi-market glucose monitoring solution.
We adapted our diabetes management solution to serve the desperate need in animal health for better glucose testing and monitoring by offering the GluCurve Pet CGM which combines both the industry first CGM for pets with the first of its kind patient management portal.
ALR Technologies Announces Second Generation GluCurve Pet CGM for Diabetic Cats and Dogs
ALR Technologies Inc. announces the issuance of a purchase order for the first shipment of second generation CGM hardware used in the GluCurve Pet CGM
ALR Technologies Announces Sales Guidance for Q4 2022, Q1 2023, and Completion of the GluCurve Pet CGM Manufacturing Agreement
ALR Technologies Inc. announced the completion of a long-term manufacturing and supply agreement with Infinovo Medical Co. Ltd (“Infinovo”) for the Continuous Glucose Monitor (CGM) hardware used in the GluCurve Pet CGM
ALR Technologies Announces Co-branded Distribution Partnership with Covetrus for GluCurve Pet CGM, the First Continuous Glucose Monitoring System for Diabetic Pets
After meeting with many of the largest animal-health companies, Covetrus stood out as the clear choice as our partner to launch the GluCurve Pet CGM
Why invest in ALRT?
We believe diabetes is among the top drivers of healthcare costs, morbidity, and mortality because of two reasons, Clinical Inertia- failure to advance therapy on a timely basis, and patient self-management. We have worked to solve these two issues through first of their kind features such as active patient management, patent pending predictive A1C, FDA cleared insulin dose adjustments, non-insulin therapy advancements, direct meter uploads, data processing, remote care, and more!